Top Buy
| Security | Buy | Sell | Buy (1M) ▼ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| PTC Therapeutics Inc. | 13 | 5 | 2 | 0 | €28.20 | €41.81 | 48.277% |
| Agios Pharmaceuticals Inc. | 6 | 0 | 2 | 0 | €31.00 | €38.99 | 25.770% |
| Viking Therapeutics Inc | 5 | 0 | 2 | 0 | €68.38 | €100.00 | 46.242% |
| X4 Pharmaceuticals, Inc. | 5 | 0 | 2 | 0 | €0.98 | €2.78 | 183.400% |
| Anika Therapeutics | 5 | 0 | 1 | 0 | €26.40 | €28.29 | 7.162% |
| Sanofi S.A. | 5 | 0 | 1 | 0 | €94.47 | €99.50 | 5.324% |
| Charles River Labs Intl | 10 | 0 | 1 | 0 | €212.20 | €248.57 | 17.139% |
| Novo Nordisk A/S ADR | 17 | 1 | 1 | 0 | €119.50 | €130.44 | 9.153% |
| Xeris Biopharma Holdings Inc. | 5 | 0 | 1 | 0 | €1.64 | €4.16 | 153.887% |
| Nektar Therapeutics | 3 | 1 | 1 | 0 | €1.63 | €3.70 | 126.994% |
| Enlivex Therapeutics Ltd. | 1 | 0 | 1 | 0 | €1.43 | - | - |
| Purple Biotech Ltd. ADR | 5 | 0 | 1 | 0 | €0.51 | €9.21 | 1723.168% |
| Merck & Co. Inc. | 28 | 1 | 1 | 0 | €120.80 | €124.93 | 3.418% |
| Iovance Biotherapeutics Inc. | 20 | 4 | 1 | 1 | €10.18 | €22.78 | 123.726% |
| Catalyst Pharmaceutical Partners Inc | 11 | 0 | 1 | 0 | €14.80 | €24.13 | 63.117% |
| Novavax Inc. | 3 | 3 | 1 | 0 | €8.26 | €82.00 | 893.097% |
| Teva Pharmaceutical Industries Ltd ADR | 12 | 1 | 1 | 1 | €15.10 | €17.65 | 16.856% |
| Dr. Reddy's Laboratories Ltd. ADR | 6 | 1 | 1 | 0 | €64.50 | €74.65 | 15.729% |
| Eledon Pharmaceuticals Inc. | 5 | 0 | 1 | 0 | €2.22 | €12.18 | 448.577% |
| Viracta Therapeutics Inc. | 1 | 0 | 1 | 0 | €0.75 | - | - |
| Chromadex Corp | 11 | 2 | 1 | 0 | €3.42 | €5.58 | 63.035% |
| ImmunityBio Inc. | 3 | 0 | 1 | 0 | €7.52 | €10.00 | 32.908% |
| Vanda Pharmaceuticals | 4 | 0 | 1 | 0 | €4.68 | €5.00 | 6.838% |
| AstraZeneca plc | 2 | 0 | 1 | 0 | €143.25 | €165.00 | 15.183% |
| aTyr Pharma Inc | 2 | 0 | 1 | 0 | €1.57 | €10.00 | 536.943% |